ISTAART Ambassador ‘25-‘26
Gate Lab Research Technician and Lab Manager
Now that the’ve wrapped #AAIC25, they are pumped to share all the excitement in this field with their local research & treatment communities! Keep your eyes peeled for them, they are set for greatness!
alz.org/ISTAARTambassadors
Now that the’ve wrapped #AAIC25, they are pumped to share all the excitement in this field with their local research & treatment communities! Keep your eyes peeled for them, they are set for greatness!
alz.org/ISTAARTambassadors
Together, you advanced science and clinical practice and have given hope to all those living with Alzheimer’s and all other dementia.
youtube.com/watch?v=6v9iL-EM9Jc
This award recognizes an @istaart.bsky.social member who has provided continued and outstanding service to the ISTAART community.
@wilcocklab.bsky.social @iusm-medneuro.bsky.social
This award recognizes an @istaart.bsky.social member who has provided continued and outstanding service to the ISTAART community.
@wilcocklab.bsky.social @iusm-medneuro.bsky.social
Our @mariacarrilloalz.bsky.social announces the Association & our philanthropic partners will launch a bridge funding program to support early career scientists who may be experiencing funding disruptions. #AAIC25
Our @mariacarrilloalz.bsky.social announces the Association & our philanthropic partners will launch a bridge funding program to support early career scientists who may be experiencing funding disruptions. #AAIC25
Meet them at alz.org/ISTAARTambassadors
@alzassociation.bsky.social
They explore the challenges of leveraging patient data—and why better access to clinical trial results is essential for advancing dementia research.
🎧alz.org/ISTAARTpodcast
They explore the challenges of leveraging patient data—and why better access to clinical trial results is essential for advancing dementia research.
🎧alz.org/ISTAARTpodcast
Drs. Mark Dubbelman and Sietske Sikkes join the ISTAART Voices podcast to explore how better access to trial data can improve patient stratification for disease-modifying therapies in Alzheimer’s research and care!
🎧alz.org/ISTAARTpodcast
Drs. Mark Dubbelman and Sietske Sikkes join the ISTAART Voices podcast to explore how better access to trial data can improve patient stratification for disease-modifying therapies in Alzheimer’s research and care!
🎧alz.org/ISTAARTpodcast